Leadership

Officers

Dr. John Keller (President)
President & CEO
Shionogi Inc.

Ms. Brianne Weingarten (Secretary)
Head of Alliance Management
Licensing & Business Development
Purdue Pharma L.P.

Mr. Shoji Yasuda (Treasurer)
President
Taisho Pharmaceutical R&D Inc.

Additional Members of
The Board of Directors

Mr. Tim Whitten
Chief Operating Officer
Taiho Oncology, Inc.

Ms. Theresa Covert
AVP, Business Development/Developed Markets,
Global Human Health
Merck & Co., Inc.

Dr. John Keller
President & CEO
Shionogi Inc.

Dr. Rana Al-Hallaq
Director, Business Development
Pfizer Inc.

Dr. Jeffrey Warmke
Senior Vice President, External Scientific Affairs & Alliance Management, Global Business Development                                                       Daiichi Sankyo Inc.

Mr. Sang Le
Senior Director of Alliance Management
Otsuka America Pharmaceuticals

Dr. Alex Chang
Executive Director Business Development
Helsinn Therapeutics (U.S.) Inc.

Dr. Toby Freyman
Director, Business Development
Shire

Dr. Hiroshi Kawai
Vice President, Business Development
Mitsubishi Tanabe Pharma Holdings America, Inc.

Mr. Mitsuo Kosaka
Vice President, U.S. Payer Markets & Corporate Strategy
Eisai Inc.

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Ms. Brianne Weingarten
Head of Alliance Management
Licensing and Business Development
Purdue Pharma L.P.

Mr. Shoji Yasuda
President
Taisho Pharmaceutical R&D Inc.

Special Advisor

Mr. Hiroyuki Kawabata
Director, Health and Welfare Dept.
JETRO New York